Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy
靶向循环内皮糖萼片段以减少脓毒性脑病
基本信息
- 批准号:9922971
- 负责人:
- 金额:$ 43.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteBehavioralBeta-glucuronidaseBindingBiologicalBlood - brain barrier anatomyBlood VesselsBrainBrain InjuriesBrain-Derived Neurotrophic FactorCause of DeathCharacteristicsChargeChronicCognitionCollaborationsCritical CareDementiaDevelopmentDiagnosticDistantElectrophysiology (science)EncephalopathiesEndotheliumEndotoxemiaExhibitsFaceFunctional disorderGlycobiologyGlycocalyxGlycosaminoglycansGrowth FactorHeparitin SulfateHippocampus (Brain)HumanIndustrializationInfectionInjuryInjury to KidneyInternationalInterruptionInvestigationLaboratoriesLearningLipopolysaccharidesLong-Term PotentiationMass Spectrum AnalysisMeasuresMediatingMediator of activation proteinMemoryModelingModernizationMorbidity - disease rateMusNeurocognitiveNeurocognitive DeficitNeuronal InjuryOligosaccharidesOrganOutcomePathway interactionsPatientsPenetrationPharmacologyPhenotypePlasmaProcessProductivityResearch PersonnelResidual stateResolutionSamplingSepsisSignal PathwaySignal TransductionSliceSocietiesStructureSurface Plasmon ResonanceSurvivorsSynaptic plasticityTestingTherapeuticTherapeutic InterventionTimeTransgenic Organismsbasececal ligation punctureclinically relevantcohortconditioned fearexperienceexperimental studyextracellularheparanasehuman mortalityimprovedin vivointraperitoneallung injurymouse modelneurocognitive testnovelorgan injurypolymicrobial sepsispreventresponsesepticseptic patientssugartherapeutic targetvascular bed
项目摘要
PROJECT SUMMARY/ABSTRACT
Sepsis is a major cause of death and morbidity in both developing and industrialized societies. While great
effort has been dedicated to the study of acute organ injury during sepsis, little is known about the mechanisms
underlying the chronic morbidities faced by sepsis survivors. One such morbidity is septic neurocognitive
dysfunction (also known as chronic septic encephalopathy), a common, severe illness characterized by the
accelerated onset of dementia. Recently, the laboratories of Dr. Eric Schmidt (with extensive expertise in the
study of sepsis and glycobiology) and Dr. Paco Herson (with extensive expertise in the study of brain injury)
have partnered to establish a mouse model of septic neurocognitive dysfunction. This model has allowed the
Schmidt and Herson laboratories to explore a novel hypothesis: that septic degradation of the systemic
endothelial glycocalyx (a heparan sulfate (HS)-rich layer lining the vascular lumen) releases biologically-active,
circulating HS fragments capable of penetrating the hippocampus and disrupting growth factor signaling
pathways implicated in cognition. This newly-created collaboration will explore this hypothesis by performing
ex vivo electrophysiological studies of living mouse hippocampi, in vivo mechanistic investigations of
neurocognitive dysfunction in mouse survivors of endotoxemia or polymicrobial sepsis, and mass spectrometry
studies of human plasma samples collected from a cohort of septic patients who underwent rigorous testing of
neurocognitive function after sepsis resolution. This novel proposal, which departs from the
“hyperinflammatory” dogma of septic organ injury, promises to identify a mechanistic pathway that is not only
responsible for the development of septic neurocognitive dysfunction, but is amenable to therapeutic targeting
even in established sepsis.
项目摘要/摘要
败血症是发展中国家和工业化社会的死亡和发病率的主要原因。虽然很棒
努力一直致力于研究败血症期间急性器官损伤的研究,对这些机制知之甚少
败血症存活所面临的慢性病的基础。一种这样的发病率是化脓性神经认知
功能障碍(也称为慢性败血性脑病),一种常见的严重疾病,其为特征
加速痴呆发作。最近,埃里克·施密特(Eric Schmidt)博士的实验室(拥有广泛的专业知识
败血症和糖生物学的研究)和Paco Herson博士(在脑损伤研究方面具有广泛的专业知识)
已经建立了败血性神经认知功能障碍的小鼠模型。该模型允许
Schmidt和Herson实验室探索一个新的假设:系统性的化粪池降解
内皮糖脂(硫酸乙酰肝素(HS) - 富含血管腔的富含层)释放生物活性,
循环的HS片段能够穿透海马并破坏生长因子信号传导
认知实施的途径。这种新创建的合作将通过执行该假设来探讨这一假设
活体小鼠海马的体内电生理研究,体内机械研究
内毒性血症或多数症败血症和质谱法的小鼠存活中的神经认知功能障碍
从一群接受严格测试的化粪池患者中收集的人血浆样品的研究
败血症后神经认知功能。这个小说的提议,偏离了
化粪池损伤的“高炎”教条,有望确定不仅是的机械途径
负责败血性神经认知功能障碍的发展,但可以接受治疗靶向
即使在已建立的败血症中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paco S Herson其他文献
Paco S Herson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paco S Herson', 18)}}的其他基金
Vascular mechanisms of sepsis-induced cognitive dysfunction
脓毒症所致认知功能障碍的血管机制
- 批准号:
10681857 - 财政年份:2023
- 资助金额:
$ 43.9万 - 项目类别:
New approach to sustained neuroprotection and enhanced recovery following acute ischemic stroke
急性缺血性中风后持续神经保护和促进康复的新方法
- 批准号:
10584833 - 财政年份:2022
- 资助金额:
$ 43.9万 - 项目类别:
Targeting TRPM2 channels to improve synaptic and cognitive function after cerebral ischemia
靶向TRPM2通道改善脑缺血后的突触和认知功能
- 批准号:
9203070 - 财政年份:2016
- 资助金额:
$ 43.9万 - 项目类别:
Bead-Based Approach for Combined Mechanical and Pharmacological Treatment of Acut
基于珠子的急性急性机械和药物联合治疗方法
- 批准号:
8742017 - 财政年份:2013
- 资助金额:
$ 43.9万 - 项目类别:
Bead-Based Approach for Combined Mechanical and Pharmacological Treatment of Acut
基于珠子的急性急性机械和药物联合治疗方法
- 批准号:
8637561 - 财政年份:2013
- 资助金额:
$ 43.9万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
7370188 - 财政年份:2007
- 资助金额:
$ 43.9万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
7616219 - 财政年份:2007
- 资助金额:
$ 43.9万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
8103597 - 财政年份:2007
- 资助金额:
$ 43.9万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
7501939 - 财政年份:2007
- 资助金额:
$ 43.9万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
7846096 - 财政年份:2007
- 资助金额:
$ 43.9万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于大塑性变形晶粒细化的背压触变反挤压锡青铜偏析行为调控研究
- 批准号:52365047
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
锡(铋、铟)氧/硫化物在CO2电还原过程中的重构行为与催化机制研究
- 批准号:52372217
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
中熵合金低温协同强化及其多场耦合环境下应力腐蚀行为的研究
- 批准号:52371070
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
城市污水厂生物除臭系统生物膜微界面微生物逸散行为及机制
- 批准号:52370026
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Title: Development and Validation of Therapy for GM1 Gangliosidosis
标题:GM1 神经节苷脂沉积症疗法的开发和验证
- 批准号:
10678309 - 财政年份:2023
- 资助金额:
$ 43.9万 - 项目类别:
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
CLN1巴顿病脑室内酶替代疗法的研制
- 批准号:
10483470 - 财政年份:2018
- 资助金额:
$ 43.9万 - 项目类别: